Form 4 for CNMD CONMED Corp
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-02 · accession 0001127602-25-016762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-04 | 2025-06-03 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | +479 | 16.9K | +3% | $0 |
| DM | 2025-06-04 | 2025-06-02 | CNMD | Farkas Charles | Dir | A - Grant | $0.00 | +8,729 | 668 | New | $0 |
| D | 2025-06-04 | 2025-06-03 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | -479 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | M | A | 479 | $0.00 | 16,859 | D | — | — | |
| 2 | Derivative | Options To Purchase Common Stock | 2025-06-02 | A | A | 8,061 | $0.00 | 8,061 | D | $55.38 · 2026-06-02 to 2035-06-02 | 8,061 Common Stock | (F1) The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. |
| 3 | Derivative | RSUs (Restricted Stock Units) | 2025-06-03 | M | D | 479 | $0.00 | 0 | D | $0.00 · 2025-06-03 to 2034-06-03 | 479 Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
| 4 | Derivative | RSUs (Restricted Stock Units) | 2025-06-02 | A | A | 668 | $0.00 | 668 | D | $0.00 · 2026-06-02 to 2035-06-02 | 668 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |